Genomica Revenues Up on Software Sales, Losses Widen | GenomeWeb

NEW YORK, May 1 – Genomica said Tuesday its first quarter revenues rose 20 percent to $444,000 compared with $370,000 in the same period last year.

Genomica’s operating expenses rose to $7.7 million for the quarter, up from $6.8 for the previous-year period, stemming from higher R&D and sales and marketing expenses. General and administrative expenses decreased to $2.1 million from $2.5 million for the first quarter of 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.